Related Experiment Video
Updated: Jun 17, 2025

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Multisystemic Inflammatory Syndrome in Children (MIS-C) With COVID-19 and Kidney Involvement: Poor Outcomes in a Case
Nora S Alghamdi1, Lujain Aletani2, Ibrahim Sandokji3
1Pediatric Department, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Insights
Multisystemic inflammatory syndrome in children (Mis-C) is a severe COVID-19 complication. This study highlights its high mortality rate and the critical need for prompt recognition and treatment in pediatric patients.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Pediatric rheumatology
Background:
- Multisystemic inflammatory syndrome in children (Mis-C) emerged as a serious complication of SARS-CoV2 infection in May 2020.
- Mis-C presents with multisystemic involvement, affecting respiratory and gastrointestinal systems, and is associated with significant morbidity and mortality in pediatric populations.
Purpose of the Study:
- To describe the clinical presentation, management, and outcomes of children diagnosed with Mis-C.
- To emphasize the severity and potential lethality of Mis-C in the pediatric population.
Main Methods:
- Retrospective case series of 6 pediatric patients admitted to tertiary care hospitals with Mis-C.
- Clinical data including symptoms, comorbidities, laboratory findings (acidosis, acute kidney injury, electrolyte disturbances), imaging, and treatments were reviewed.
Main Results:
- All 6 patients presented with respiratory and gastrointestinal symptoms.
- 5 out of 6 patients (83%) died during hospitalization.
- Patients exhibited acidosis, acute kidney injury, electrolyte disturbances, coagulopathy, thrombocytopenia, and chest X-ray abnormalities.
Conclusions:
- Multisystemic inflammatory syndrome in children is a rare but severe complication of SARS-CoV2 infection.
- Prompt recognition and management of multisystem involvement are crucial for improving outcomes in pediatric Mis-C cases.
Abstract:
Multisystemic inflammatory syndrome (Mis-C) has emerged in May 2020 as a serious complication of coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). A total of 6 children presented to tertiary care hospitals with Mis-C, of which 5 (83%) have died during hospitalization. All included patients presented with respiratory symptoms (ranged from mild to severe acute respiratory distress syndrome) and gastrointestinal symptoms. Most of the patients are known to have medical illnesses. Pediatric Risk of Mortality (PRISM) IV score ranged from 3 to 87. All patients developed acidosis and varying stages of acute kidney injury and electrolyte disturbances. All were treated for coagulopathy, thrombocytopenia, bacterial infections as well as antiviral medications (either ritonavir or lopinavir). Most patients had chest X-ray changes either unilateral or bilateral lung changes. Multisystemic inflammatory syndrome is a rare, yet serious complication of SARS-CoV2 infection in children. Multisystem involvement should be anticipated and promptly treated.
More Related Videos
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Nephrons

